# Tags

Autoimmune Disease Diagnostics Market Hits US$5.32 Billion in 2023, Anticipated to Surge at 7.17% CAGR from 2024 to 2030 ⅼ Renub Research

Global Autoimmune Disease Diagnostics market is projected to be valued at around US$ 8.64 Billion by 2030, as per Renub Research. Autoimmune disease diagnostics normally contain a combination of blood markers, specific signs, and sometimes a tissue biopsy. Autoimmune disorders broaden whilst the immune device attacks its cells due to abnormalities. The failure to detect immune cells, tissues, & organs and produce autoantibodies targeting these cells reasons the immune system to malfunction. Therefore, several tasks are carried out via businesses to create focus approximately autoimmune diseases and their socioeconomic impact, thereby boosting the global usage rates of autoimmune disease diagnostics. Additionally, improved laboratory automation and technological diagnostic improvements drive the expansion of the autoimmune ailment diagnostics market.


The global autoimmune disease diagnostics market reached US$5.32 Billion in 2023 and is forecast to grow at a CAGR of 7.17% from 2024 to 2030. The growing burden of autoimmune diseases in different parts of the sector, coupled with growing recognition of health and diseases, creates the need for diagnostics for the early detection of diseases, as a consequence of the marketplace’s boom. The introduction of technological developments and growing lab automation rates are estimated to increase the fuel market. Clinicians are adopting advance technology to conduct a multiple test simultaneously, with faster and more specific results. The gradual turnaround time related to conventional disease diagnostic techniques and less standardized assessments for over 80 kinds are some of the shortcomings encouraging laboratories to move towards automation. Moreover, favorable government initiatives are anticipated to reinforce market dynamics positively. Organizations along with the Autoimmunity Centers of Excellence, the Cooperative Study Group for Autoimmune Disease Prevention, and the North American Rheumatoid Arthritis Consortium actively educate sufferers and healthcare experts regarding proper diagnosis and treatment.


Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=autoimmune-disease-diagnostic-market-p.php


Diagnostics equipment firmly holds the top spot in the global autoimmune disease diagnostics market.


Diagnostics Equipment is the primary leader in the global autoimmune disease diagnostics market, owing to its advanced capabilities and widespread adoption. With its precise and reliable testing methods, diagnostic equipment is crucial in accurately identifying autoimmune conditions, enabling timely intervention and treatment. Its versatility allows for detecting various autoimmune diseases, facilitating comprehensive patient care. As the demand for accurate diagnostic tools continues to rise, diagnostic equipment remains at the forefront, driving advancements in autoimmune disease diagnosis and management. Its pivotal role in healthcare underscores its position as the leading solution in the global autoimmune disease diagnostics market.


Systemic autoimmune diseases claim a notable share of the global autoimmune disease diagnostics market.


Systemic autoimmune diseases (SADs) hold a significant share in the global autoimmune diagnostics market due to their complex nature and varied manifestations. Conditions like rheumatoid arthritis, lupus, and Sjögren’s syndrome affect multiple organs, necessitating an accurate diagnosis for effective management. This drives demand for advanced diagnostic tools capable of identifying specific autoimmune markers. Consequently, innovative assays, imaging techniques, and biomarker detection methods tailored to SADs have emerged. With increasing awareness of autoimmune disorders and diagnostic advancements, SADs are expected to maintain and potentially expand their prominence in the autoimmune diagnostics market.


Rheumatic disease diagnostics claim a significant portion of the autoimmune disease diagnostic market.


Rheumatic disease diagnostics, crucial for managing conditions like rheumatoid arthritis and lupus, hold a significant share in autoimmune disease diagnostics. Given their complexity, accurate diagnosis is vital, driving the demand for advanced tools to identify specific biomarkers. Medical imaging, blood tests, and molecular diagnostics are key in this process, enabling early intervention. As awareness grows and diagnostic technology advances, the prominence of rheumatic disease diagnostics in the autoimmune disease market is set to endure and potentially develop further.


Diagnostic centers are anticipated to secure a notable portion of the global autoimmune disease diagnostics market.

Diagnostic centers are poised to capture a substantial share of the global autoimmune disease diagnostics market. These centers are crucial in providing accurate and efficient diagnostic services for autoimmune disorders such as rheumatoid arthritis, lupus, and multiple sclerosis. Equipped with advanced medical technologies and staffed by skilled healthcare professionals, diagnostic centers offer a wide range of tests and procedures to detect autoimmune diseases promptly. Patients rely on these facilities for timely diagnosis, essential for initiating appropriate treatment and disease management strategies. With the increasing prevalence of autoimmune conditions worldwide, the demand for diagnostic services provided by specialized centers is expected to grow, solidifying their position in the diagnostic market for autoimmune diseases.


With more than half of the global population residing in the Asia-Pacific region, it confronts an increasing challenge posed by autoimmune diseases.


The Asia-Pacific region plays a crucial role in the global autoimmune diseases diagnostics market, driven by its significant population and rising disease burden. Factors like changing lifestyles, urbanization, and genetic predispositions contribute to the growing prevalence of autoimmune diseases in the region. This has increased the demand for advanced diagnostic technologies and healthcare services. Moreover, improvements in healthcare infrastructure, higher healthcare expenditure, and government initiatives aimed at enhancing healthcare accessibility are fueling market expansion. Asia-Pacific presents substantial growth potential for stakeholders in the autoimmune diseases diagnostics market as efforts to address early disease detection and prevention continue to gain traction in the region.


Key Player


The global market for autoimmune disease diagnostics includes companies like Abbott Laboratories, Bio-Rad Laboratories, Roche Diagnostics, Siemens Healthineers, Bio Merieux SA, Myriad Genetics, Inc., Quest Diagnostics Incorporated, and Thermo Fisher Scientific Inc.


Product – Market breakup in 3 viewpoints:

  1. Therapeutic & Monitoring Equipment
  2. Diagnostics Equipment
  3. Drugs


Types – Market breakup in 2 viewpoints:

  1. Systemic Autoimmune Disease Diagnostics
  2. Localized Autoimmune Disease Diagnostics


Indication – Market breakup in 5 viewpoints:

  1. Rheumatic Disease
  2. Diabetes
  3. Multiple Sclerosis
  4. Inflammatory Bowel Disease
  5. Others


End-Users – Market breakup in 3 viewpoints:

  1. Hospitals
  2. Diagnostics Centers
  3. Others


Countries – Market Breakup into 25 Countries Autoimmune Diseases Diagnostics Industry

  1. North America


1.1    United States

1.2    Canada


  1. Europe


2.1    France

2.2    Germany

2.3    Italy

2.4    Spain

2.5    United Kingdom

2.6    Belgium

2.7    Netherlands

2.8    Turkey


  1. Asia Pacific


3.1    China

3.2    Japan

3.3    India

3.4    South Korea

3.5    Thailand

3.6    Malaysia

3.7    Indonesia

3.8    Australia

3.9    New Zealand


  1. Latin America


4.1    Brazil

4.2    Mexico

4.3    Argentina


  1. Middle East & Africa


5.1    Saudi Arabia

5.2    UAE

5.3    South Africa


All the Key players have been covered from 3 Viewpoints:

  • Overview
  • Recent Developments
  • Revenue Analysis


Company Analysis:

  1. Abbott Laboratories
  2. Bio-Rad Laboratories
  3. Roche Diagnostics
  4. Siemens Healthineers
  5. Bio Merieux SA
  6. Myriad Genetics, Inc.
  7. Quest Diagnostics Incorporated
  8. Thermo Fisher Scientific Inc.


Browse Related Report:

Liquid Biopsy Market: https://www.renub.com/liquid-biopsy-market-p.php

Point-of-Care Diagnostics Market: https://www.renub.com/point-of-care-diagnostic-market-p.php

Next Generation Sequencing Market: https://www.renub.com/next-generation-sequencing-market-p.php


About the Company: 

Renub Research is a Market Research and Information Analysis company with more than 15 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 7000 syndicated reports and worked on more than 500 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.

Contact Us:

Renub Research         

Phone No: +91-120-421-9822 (IND)

Email: info@renub.com

LinkedIn: https://in.linkedin.com/company/renub-research

Web: www.renub.com

Leave a comment